PRIMYCIN (cas 113441-12-6) II. New macrocyclic lactones via translactonization
-
Add time:08/16/2019 Source:sciencedirect.com
PRIMYCIN (cas 113441-12-6), a mixture of macrolide antibiotic agents, on treatment with nucleophiles is transformed in a reversible reaction into water-soluble compounds with the same molecular weights as that of the starting materials. Detailed 2D NMR spectroscopic studies of the separated components revealed that the new compounds, named “pseudo-primycins”, are formed by a unique C35 → C37 ring expansion via translactonization.
We also recommend Trading Suppliers and Manufacturers of PRIMYCIN (cas 113441-12-6). Pls Click Website Link as below: cas 113441-12-6 suppliers
Prev:The composition of PRIMYCIN (cas 113441-12-6)☆
Next:Effects of PRIMYCIN (cas 113441-12-6) on the synthesis of tryptophan pyrrolase) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Inhibition of growth of Euglena and Astasia by PRIMYCIN (cas 113441-12-6) and prevention of the effect by polynucleotides08/20/2019
- Preparation of the homologous components (A1, A2 And B) of PRIMYCIN (cas 113441-12-6) by thin-layer chromatography08/19/2019
- The effect of PRIMYCIN (cas 113441-12-6) on the intracellular monovalent ion and water contents of rat hepatocytes as revealed by energy dispersive X-ray microanalysis and interference microscopy08/18/2019
- Effects of PRIMYCIN (cas 113441-12-6) on the synthesis of tryptophan pyrrolase08/17/2019
- The composition of PRIMYCIN (cas 113441-12-6)☆08/15/2019
- Direct in vivo interaction of the antibiotic PRIMYCIN (cas 113441-12-6) with the plasma membrane of Candida albicans: An EPR study08/14/2019
- Re-evaluation of in vitro activity of PRIMYCIN (cas 113441-12-6) against prevalent multiresistant bacteria08/13/2019
- Full length articleToxicology studies of PRIMYCIN (cas 113441-12-6)-sulphate using a three-dimensional (3D) in vitro human liver aggregate model08/12/2019
